ArticleFrontiers in immunology2026

Editorial: Understanding and controlling adverse effects in myeloma patients treated with T cell redirecting immunotherapies.

Jakub Krejcik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.